Case Study: Pedestrian Hit by Car Overcomes Insurance Denial Through Pharmacy Lien
James Wong — Founder & Pharmacist, LienScripts | July 16, 2024 | 9 min read
When a pedestrian struck in a crosswalk had her health insurance deny coverage for accident-related prescriptions, a pharmacy lien program provided immediate medication access. The unbroken treatment record ultimately supported a $165,000 settlement against an insurer that initially offered $15,000.
Case Study: Pedestrian Hit by Car Overcomes Insurance Denial Through Pharmacy Lien
Insurance denials are one of the most frustrating obstacles personal injury patients face. Even patients who have health insurance often discover that their carrier refuses to cover medications related to an auto accident, citing third-party liability exclusions or coordination of benefits rules. This case study examines how a pharmacy lien bridged the gap when insurance failed — and how continuous medication documentation transformed a lowball offer into a fair settlement.
[!KEY] Angela, 38, was struck in a crosswalk and had her employer PPO deny all accident-related medication claims — a pharmacy lien provided 7 months of uninterrupted access, and tracked Sumatriptan utilization data that proved post-traumatic headaches and supported a $165,000 settlement from a $15,000 initial offer.
Patient Profile
- Patient: Angela Foster (name changed), 38-year-old female, elementary school teacher
- Incident: Struck by a vehicle while crossing in a marked crosswalk in downtown Sacramento. The driver was making a right turn on red and failed to yield to pedestrians.
- Injuries: Pelvic bone bruise, bilateral knee contusions, lumbar strain with muscle spasm, acute stress disorder progressing to PTSD, chronic tension headaches
- Attorney: Robert Kimura (name changed), solo practitioner specializing in pedestrian and bicycle accidents
- Insurance situation: Angela had health insurance through her employer (a school district PPO), but the carrier denied all accident-related claims citing third-party liability. The at-fault driver had a $50,000/$100,000 auto policy.
- Treatment duration: 7 months of pharmacological management
The Problem: Health Insurance Denies Everything
Angela was crossing the street on her lunch break when a sedan struck her at approximately 15 mph. She was thrown onto the hood, rolled off, and landed on the pavement. Bystanders called 911. The ER visit was covered by her health insurance after a fight with the billing department, but when her orthopedist and primary care physician began prescribing ongoing medications, the insurance company drew a hard line.
The denial letters arrived within two weeks of the first claims:
"Benefits are not payable for services related to injuries for which a third party may be liable. Please direct all claims to the responsible party's auto insurance carrier."
Angela's prescribers had ordered:
| Medication | Purpose |
|---|---|
| Naproxen 500mg | Anti-inflammatory for pelvic/knee pain |
| Cyclobenzaprine 10mg | Muscle relaxant for lumbar spasm |
| Tizanidine 4mg | Secondary muscle relaxant (nighttime) |
| Sertraline 50mg | SSRI for PTSD/acute stress disorder |
| Sumatriptan 50mg | Migraine/tension headache (PRN) |
Angela did not cause this accident. She should not have to pay for medications caused by someone else's negligence. More importantly, her attorney knew that out-of-pocket pharmacy costs create a perverse documentation problem: retail pharmacies do not generate the kind of detailed clinical records that support a demand package.
[!KEY] When a health insurer denies accident-related medication coverage, the fastest path to treatment is a pharmacy lien — do not wait weeks fighting the denial while your client goes without prescriptions; enroll immediately and pursue the appeal in parallel.
The Insurance Runaround
Robert Kimura's office spent three weeks trying to get the health insurer to reverse the denial. They filed appeals, provided police reports proving third-party liability, and argued that the plan's coordination of benefits provision required coverage with a right of subrogation. The insurer's position was firm: no coverage for accident-related treatment.
Meanwhile, Angela's prescriptions were due for refills. She had filled the first round at a CVS out of pocket. She was not going to stop treatment — she was in genuine pain and the PTSD was affecting her ability to teach — but she resented paying for it, and her attorney was frustrated that the retail pharmacy records were bare-bones.
The Solution: Pharmacy Lien Bypasses the Insurance Problem
Robert referred Angela to LienScripts in the third week of her treatment. The transition was straightforward:
- Angela's prescribers sent new prescriptions (or transferred existing ones) to LienScripts
- LienScripts verified the lien agreement with the attorney's office
- Angela began receiving all five medications at $0 upfront cost
- The health insurance denial became irrelevant — the pharmacy lien operated independently of any insurance carrier
Clinical Monitoring
Over 7 months, the medication regimen evolved based on Angela's recovery:
| Phase | Months | Medications | Changes |
|---|---|---|---|
| Acute | 1-2 | Naproxen, Cyclobenzaprine, Tizanidine, Sertraline, Sumatriptan | Full regimen; Sumatriptan used 4-6 times/month |
| Recovery | 3-4 | Naproxen, Cyclobenzaprine (reduced), Sertraline, Sumatriptan | Tizanidine discontinued (nighttime spasms resolved); Cyclobenzaprine reduced to PRN |
| Stabilization | 5-6 | Naproxen (reduced), Sertraline, Sumatriptan (PRN only) | Cyclobenzaprine discontinued; Naproxen reduced to PRN; headaches less frequent |
| Maintenance | 7 | Sertraline, Sumatriptan (rare use) | Only PTSD medication and occasional headache treatment; approaching settlement |
The MERIT report documented every phase transition with clinical rationale, creating a narrative that showed Angela's injuries were real, her treatment was appropriate, and her recovery followed a medically expected trajectory.
The Sumatriptan Detail That Won the Case
A small but critical detail: the MERIT report tracked Angela's Sumatriptan usage by month. In months 1-2, she used 4-6 doses per month. By month 5-6, she used 1-2 doses. By month 7, she had used zero doses in the prior 30 days.
This pattern — frequent headaches immediately after the accident, gradually decreasing over time — correlated perfectly with the medical literature on post-concussive/post-traumatic headaches. It was exactly the kind of objective medication utilization data that a treating physician's testimony alone could not provide.
The Results
Settlement Impact
The at-fault driver's insurer initially offered $15,000 — a classic lowball for a pedestrian case with "soft tissue" injuries and no surgery. The adjuster's position: the injuries were minor contusions, the medications were inexpensive over-the-counter equivalents, and Angela returned to work within 6 weeks (true, but she was teaching in significant pain because she could not afford unpaid leave).
Robert's demand package included:
- Complete LienScripts medication records showing 7 months of continuous treatment
- MERIT report with clinical narrative linking each medication to specific injuries
- Sumatriptan utilization trend demonstrating post-traumatic headache pattern
- Documentation of the health insurance denial, establishing that Angela could not access her own benefits due to the accident
- A demand of $195,000, including future PTSD treatment costs
After mediation, the case settled for $165,000 — an 1,000% increase over the initial $15,000 offer. The mediator specifically noted that the pharmacy documentation was more detailed and clinically persuasive than the medical provider records.
"The mediator specifically noted that the pharmacy documentation was more detailed and clinically persuasive than the medical provider records."
Key Takeaways
For Attorneys
- Do not waste weeks fighting health insurance denials. When a health insurer denies accident-related medication claims, the fastest path to treatment is a pharmacy lien. You can still pursue the insurance denial on principle, but your client should not go without medication while you argue with an adjuster.
[!TIP] Track PRN medication utilization month by month in your demand — Angela's declining Sumatriptan usage provided objective proof of her post-traumatic headache pattern that was more persuasive than physician testimony alone.
Retail pharmacy records are not enough. A CVS or Walgreens receipt shows that a prescription was filled. It does not explain why the medication was prescribed, how the dosage was adjusted, or what the clinical outcome was. MERIT documentation fills this gap completely.
Medication utilization patterns are powerful evidence. Angela's decreasing Sumatriptan usage objectively demonstrated her headache recovery trajectory. This is the kind of data that is almost impossible to fabricate and very persuasive to mediators and adjusters.
Pedestrian cases are often undervalued. Insurance companies routinely lowball pedestrian accident claims, especially when there is no surgery.
[!KEY] Month-by-month sumatriptan utilization data — showing frequent early use declining gradually over 7 months — is exactly the kind of objective medication evidence that outperforms physician narrative alone in persuading mediators and adjusters of genuine post-traumatic neurological injury. Comprehensive medication documentation helps demonstrate the true impact of "soft tissue" injuries that are anything but soft.
For Patients
An insurance denial is not the end of the road. If your health insurance refuses to cover accident-related medications, talk to your attorney about pharmacy lien options. You should not pay out of pocket for injuries someone else caused.
Keep taking your medications. Insurance denials create a temptation to stop treatment or reduce doses. This hurts both your health and your case. A pharmacy lien eliminates the financial pressure so you can focus on recovery.
Related Resources
- Insurance Denial and Medication Access in PI Cases
- Treatment Gaps and Medication Access
- California Personal Injury Medication Rights
- Pharmacy Services for Personal Injury Clients: How It Works
This case study is a composite based on multiple real cases. Names, identifying details, and specific figures have been modified to protect privacy. Results vary by case.
Frequently Asked Questions
What happens when health insurance denies pedestrian accident medications?
When a health insurer denies pedestrian accident medication coverage citing third-party liability, a pharmacy lien provides an immediate alternative. The lien covers all prescribed medications at zero upfront cost regardless of insurance status, allowing the pedestrian accident victim to maintain continuous treatment while the insurer dispute is handled separately.
Can a pedestrian hit by a car file a claim without health insurance paying?
A pedestrian hit by a car can pursue a full personal injury claim even if health insurance denies coverage for accident-related medications. A pharmacy lien defers medication costs to the settlement so treatment never stalls due to the insurance denial. The documented treatment record built through the lien ultimately supports the claim value against the at-fault driver.
Does PTSD from a pedestrian accident qualify for medication coverage?
PTSD diagnosed following a pedestrian accident qualifies as a compensable condition in a personal injury claim when causation is documented. Pharmacy records showing consistent use of an SSRI like sertraline and tracking declining use of rescue medications like sumatriptan over time provide objective evidence of both the psychological impact and the treatment response.
How does sumatriptan usage data support a pedestrian accident claim?
Sumatriptan utilization data from pharmacy records provides a month-by-month record of headache frequency after a pedestrian accident. Frequent early use declining gradually over time correlates with the medical literature on post-traumatic headache resolution, demonstrating that headaches were accident-caused rather than pre-existing and that they improved with treatment.
Why are pedestrian accident settlements often undervalued initially?
Pedestrian accident settlements are frequently undervalued in initial offers because insurers argue soft tissue injuries are minor and medication costs are minimal. Comprehensive pharmacy documentation showing months of continuous treatment for multiple conditions, including PTSD, cervical strain, and post-traumatic headaches, shifts the evidentiary balance and supports significantly higher settlement demands.